Press Releases

Date	Title	Company
12-Dec-2022	TheraVet Optimizes Its Commercial Strategy in France With a New Distribution Agreement for Its BIOCERA-VET® Range	Businesswire
12-Dec-2022	Healthcare IT Outsourcing Market is projected to grow at a robust CAGR of 7.2% between 2022 and 2032 \| FMI	MARKITWIRED
12-Dec-2022	Intraoperative Radiation Therapy Systems Market size is expected to be valued at US$ 55.9 Million in 2022	MARKITWIRED
12-Dec-2022	Evolva statement to SER communication	Evolva Holding SA
12-Dec-2022	Preclinical Imaging Market expand at a CAGR of 3.5% to reach a valuation of ~US$ 4.7 Bn by the end of the year 2032.	MARKITWIRED
12-Dec-2022	Palliative Care Market is projected to grow at a CAGR of 7.3% between 2022 and 2032, totaling around US$ 28,518.5 Mn by 2032	MARKITWIRED
12-Dec-2022	Vascular Endothelial Growth Factor Inhibitor Market to reach a valuation of ~US$ 33.5 Bn by the year 2032 \| FMI	MARKITWIRED
12-Dec-2022	Cimeio Therapeutics Presents SCIP Platform Proof-of-Concept Data at ASH	Businesswire
12-Dec-2022	Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing	Legend Capital
12-Dec-2022	Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting	Businesswire
11-Dec-2022	Se aprueba el uso de QDENGA®▼ (vacuna tetravalente contra el dengue, de virus vivo atenuado) de Takeda en la Unión Europea	Businesswire
11-Dec-2022	MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022	MorphoSys AG
11-Dec-2022	Genentech Presents New and Updated Data for Polivy in Previously Untreated Diffuse Large B-Cell Lymphoma at ASH 2022	Businesswire
11-Dec-2022	MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting	Businesswire
11-Dec-2022	Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refractory AML at the American Society of Hematology’s (ASH) 64th Annual Meeting	Businesswire
11-Dec-2022	Interim Data From Phase III Study Presented at ASH 2022 Show Hemlibra (emicizumab-kxwh) Achieved Meaningful Bleed Control in Infants From Birth	Businesswire
10-Dec-2022	Takeda présentera des données à l’occasion du 64e congrès annuel de la Société américaine d’hématologie, démontrant son engagement envers les patients atteints de cancers hématologiques et d’autres maladies du sang	Businesswire
10-Dec-2022	Orca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th ASH Annual Meeting	Businesswire
10-Dec-2022	MorphoSys Presents Updated Tafasitamab Results in Newly Diagnosed DLBCL Patients from Final firstMIND Analysis at ASH 2022	MorphoSys AG
10-Dec-2022	MaaT Pharma Presents Compelling Consolidated MaaT013 Clinical Data at the 64th ASH Annual Meeting	Businesswire